ATE381618T1 - Polypeptidhormon phosphatonin - Google Patents

Polypeptidhormon phosphatonin

Info

Publication number
ATE381618T1
ATE381618T1 AT00971403T AT00971403T ATE381618T1 AT E381618 T1 ATE381618 T1 AT E381618T1 AT 00971403 T AT00971403 T AT 00971403T AT 00971403 T AT00971403 T AT 00971403T AT E381618 T1 ATE381618 T1 AT E381618T1
Authority
AT
Austria
Prior art keywords
polypeptide hormone
phosphatonin
hormone phosphatonin
polypeptide
hormone
Prior art date
Application number
AT00971403T
Other languages
English (en)
Inventor
Peter Rowe
Original Assignee
Univ London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9926424.4A external-priority patent/GB9926424D0/en
Application filed by Univ London filed Critical Univ London
Application granted granted Critical
Publication of ATE381618T1 publication Critical patent/ATE381618T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00971403T 1999-11-04 2000-10-31 Polypeptidhormon phosphatonin ATE381618T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43418599A 1999-11-04 1999-11-04
GBGB9926424.4A GB9926424D0 (en) 1999-11-08 1999-11-08 A novel polypeptide hormone phosphatonin

Publications (1)

Publication Number Publication Date
ATE381618T1 true ATE381618T1 (de) 2008-01-15

Family

ID=26316065

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00971403T ATE381618T1 (de) 1999-11-04 2000-10-31 Polypeptidhormon phosphatonin

Country Status (13)

Country Link
EP (2) EP1870467A1 (de)
JP (3) JP4424578B2 (de)
AR (1) AR027877A1 (de)
AT (1) ATE381618T1 (de)
AU (1) AU784294B2 (de)
CA (1) CA2389644C (de)
DE (1) DE60037536T2 (de)
DK (1) DK1230369T3 (de)
ES (1) ES2296649T3 (de)
MX (1) MXPA02004416A (de)
MY (1) MY127669A (de)
PT (1) PT1230369E (de)
WO (1) WO2001032878A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1130098A3 (de) * 2000-02-29 2003-09-10 Pfizer Products Inc. Säugetier Osteoreguline
US20020102641A1 (en) * 2000-03-24 2002-08-01 Susan Schia Vi Oncogenic osteomalacia-related gene 1
US7491691B2 (en) * 2002-05-03 2009-02-17 Sindrey Dennis R Connective tissue stimulating peptides
AU2013203943C1 (en) * 2005-09-28 2016-09-01 The Regents Of The University Of California Calcium binding peptides
AU2010210600B2 (en) 2009-02-06 2016-07-14 C3 Jian, Inc. Calcium-binding agents induce hair growth and/or nail growth
US20140107321A1 (en) * 2011-05-26 2014-04-17 Dr. Reddy's Laboratories Limited Purification of antibodies
US20230272009A1 (en) * 2020-07-17 2023-08-31 Hiroshima University Peptide, Peptide Salt, Pharmaceutical Composition and Biological Tissue Calcification Inhibitor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0679716A4 (de) * 1993-11-12 1999-06-09 Kenichi Matsubara Genetische Signaturen.
CN100359015C (zh) * 1998-05-18 2008-01-02 伦敦大学专科学院 多肽激素磷酸盐沉着因子
GB9810681D0 (en) * 1998-05-18 1998-07-15 Royal Free Hosp School Med Hormone
EP1130094A3 (de) * 1999-07-08 2001-11-21 Helix Research Institute Primer zur Synthese von vollständigen cDNA Klonen und ihre Verwendung
EP1130098A3 (de) * 2000-02-29 2003-09-10 Pfizer Products Inc. Säugetier Osteoreguline
EP1293568A4 (de) * 2000-06-21 2005-10-26 Takeda Pharmaceutical Protein und dessen dns

Also Published As

Publication number Publication date
ES2296649T3 (es) 2008-05-01
AR027877A1 (es) 2003-04-16
AU784294B2 (en) 2006-03-02
MY127669A (en) 2006-12-29
CA2389644C (en) 2013-02-26
AU1027201A (en) 2001-05-14
JP4424578B2 (ja) 2010-03-03
EP1230369A2 (de) 2002-08-14
EP1870467A1 (de) 2007-12-26
JP5208021B2 (ja) 2013-06-12
MXPA02004416A (es) 2002-09-02
WO2001032878A3 (en) 2001-11-15
JP2013059334A (ja) 2013-04-04
JP2009159975A (ja) 2009-07-23
PT1230369E (pt) 2008-02-15
JP2003513631A (ja) 2003-04-15
DE60037536T2 (de) 2008-12-11
EP1230369B1 (de) 2007-12-19
DE60037536D1 (en) 2008-01-31
WO2001032878A2 (en) 2001-05-10
DK1230369T3 (da) 2008-03-31
CA2389644A1 (en) 2001-05-10

Similar Documents

Publication Publication Date Title
DE69920011D1 (de) Rekombinanter venezolanische-equine-pferdeenzephalitis-virusimpstoff
NO2010013I1 (no) Rekombinant FSH-CTP
NO982097L (no) Peptider
NO982098L (no) Peptider
PT926158E (pt) Hormona paratiroide cristalina
IS6040A (is) Valdekoxib efnablöndur
NO20025893L (no) Veksthormon sekretagoga
NO20020151D0 (no) Veksthormonformuleringer
GB9923177D0 (en) Novel polypeptide
DE69933647D1 (de) Rekombinante lysophosphatidsäure - phosphatase.
EP1197556A4 (de) NüTZLICHE POLYPEPTIDE
FR2791348B1 (fr) POLYPEPTIDE Npt2B
DK1230369T3 (da) Polypeptidhormon phosphatonin
DE50004258D1 (de) Transportvorrichtung
EP1159288A4 (de) Alpha-conotoxin-peptide
EP1162269A4 (de) Polypeptid
DE50010867D1 (de) Abdeckvorrichtung
GB9923889D0 (en) Novel polypeptide
NO20013933D0 (no) Peptider
EP1179540A4 (de) Neue polypeptide
NO20012283D0 (no) Koblede peptider
EP1151100A4 (de) Tau-conotoxin peptide
GB9918680D0 (en) Polypeptide
DE50009295D1 (de) Vernetzerfreie zubereitungen
NO20021244L (no) Subenhet-optimaliserte fusjonsproteiner

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1230369

Country of ref document: EP